PLPL Stock Overview
Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Plandaí Biotechnology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.00015 |
| 52 Week High | US$0.0007 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 11 Month Change | 50.00% |
| 3 Month Change | 0% |
| 1 Year Change | -25.00% |
| 33 Year Change | -66.67% |
| 5 Year Change | -75.00% |
| Change since IPO | -99.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| PLPL | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 2.5% | 1.0% |
| 1Y | -25.0% | 15.6% | 31.4% |
Return vs Industry: PLPL underperformed the US Biotechs industry which returned 15.6% over the past year.
Return vs Market: PLPL underperformed the US Market which returned 30.7% over the past year.
Price Volatility
| PLPL volatility | |
|---|---|
| PLPL Average Weekly Movement | 88.7% |
| Biotechs Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PLPL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PLPL's weekly volatility (89%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Roger Baylis-Duffield | www.plandaibiotech.com |
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa.
Plandaí Biotechnology, Inc. Fundamentals Summary
| PLPL fundamental statistics | |
|---|---|
| Market cap | US$1.33m |
| Earnings (TTM) | -US$4.32m |
| Revenue (TTM) | US$338.48k |
0.0x
P/S Ratio0.0x
P/E RatioIs PLPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PLPL income statement (TTM) | |
|---|---|
| Revenue | US$338.48k |
| Cost of Revenue | US$907.48k |
| Gross Profit | -US$568.99k |
| Other Expenses | US$3.75m |
| Earnings | -US$4.32m |
Last Reported Earnings
Sep 30, 2016
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PLPL perform over the long term?
See historical performance and comparison